13-cis- retinoic acid for use in the preparation of a medicament for treating conglobate and nodulocystic acne

摘要

Nodulocystic and conglobate acne in humans can be alleviated by the oral administration of 13-cis-retinoic acid or a derivative thereof. The active ingredient is administered in a dosage of from about 1.5 to about 3 mg/kg of body weight per day for a period of from about two to about four weeks.